Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ConHeal eye drops for severe conjunctivochalasis
ISRCTN81112701Phase 2Completed
- Sponsor
- Semmelweis University
- Start
- Aug 2012
- Modality
- Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of LO2A in conjunctivochalasis (CCH) and dry eye syndrome (DED), sponsored by Semmelweis University. Primary endpoint: Change in LId-Parallel COnjunctival Folds degree. Started Aug 2012; status: completed.
02
Drugs
LO2A
03
Conditions
conjunctivochalasis (CCH)dry eye syndrome (DED)
Beyond the preview
Go deeper on ISRCTN81112701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN81112701.